Common adverse reactions include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation, and abdominal pain
Sawhney says it is recommended to come down 1-2 steps in the equivalent dosing to increase the likelihood of tolerability. In general, healthcare providers aim for the lowest effective dose for each patient
These agonists not only enhance GLP-1 release but also suppress the expression of pro-inflammatory cytokines, including IL-2, IL-17a, interferon-, and TNF- (Yusta et al., 2015)
Carolynn Francavilla, an obesity medicine physician and vice president of the Obesity Medicine Association
I really need to have answers